HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

sipatrigine

a glutamate release inhibitor which protects against focal cerebral ischemic damage
Also Known As:
4-amino-2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)pyrimidine; 619C89; BW 619C89; BW-619C89; BW619C89
Networked: 22 relevant articles (1 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Tsai, Shih-Jen: 1 article (01/2008)
2. Beart, P M: 1 article (07/2004)
3. Callaway, J K: 1 article (07/2004)
4. Castillo-Melendez, M: 1 article (07/2004)
5. Giardina, S F: 1 article (07/2004)
6. Jarrott, B: 1 article (07/2004)
7. Krstew, E K: 1 article (07/2004)
8. Hainsworth, Atticus H: 1 article (02/2003)
9. Lambert, David G: 1 article (02/2003)
10. Nelson, Rachael M: 1 article (02/2003)

Related Diseases

1. Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
2. Brain Ischemia (Cerebral Ischemia)
3. Stroke (Strokes)
4. Infarction (Infarctions)
5. Ischemia

Related Drugs and Biologics

1. Glutamic Acid (Glutamate)
2. Sodium Channel Blockers
3. Neuroprotective Agents
4. Anticonvulsants (Antiepileptic Drugs)
5. Lamotrigine (Lamictal)
6. CNS 1237
7. sipatrigine
8. Sodium Channels (Sodium Channel)
9. N-Methylaspartate (NMDA)
10. Salts

Related Therapies and Procedures

1. Intravenous Infusions
2. Therapeutics
3. Oral Administration